CM
OCUL icon

Caption Management’s Ocular Therapeutix OCUL Stock Holding History

Caption Management’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.24M Buy
+382,759
New +$3.65M 0.15% 664
2024
Q4 		– Sell
-22,900
Closed -$199K – 1954
2024
Q3 		$199K Hold
22,900
– – 0.02% 1066
2024
Q2 		$157K Buy
+22,900
New +$141K 0.02% 985
2023
Q1 		– Sell
-25,000
Closed -$70.3K – 1629
2022
Q4 		$70.3K Buy
+25,000
New +$82.8K 0.01% 1154
2020
Q1 		– Sell
-32,800
Closed -$162K – 1129
2019
Q4 		$130K Sell
32,800
-7,200
-18% -$25K 0.03% 744
2019
Q3 		$122K Buy
+40,000
New +$179K 0.04% 629

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return